As previously disclosed by UpHealth, Inc. (the “Company”) in its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on September 19, 2023, on September 19, 2023, UpHealth Holdings, Inc., a wholly-owned subsidiary of the Company (“UpHealth Holdings”), filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). Furthermore, as previously disclosed by the Company, on October 20, 2023, two of UpHealth Holdings’ wholly-owned subsidiaries, Thrasys, Inc. (“Thrasys”) and Behavioral Health Services, LLC (“BHS”), and each of the subsidiaries of Thrasys and BHS (such subsidiaries, collectively with UpHealth Holdings, Thrasys and BHS, being referred to individually herein and collectively as the “Debtors”), filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. The Chapter 11 cases of the Debtors are being jointly administered under the caption In re UpHealth Holdings, Inc., Case No. 23-11476 (Bankr. D. Del.) (the “Bankruptcy Case”), for procedural purposes only.
Furthermore, as previously disclosed by the Company in its Current Report on Form 8-K filed with the SEC on May 20, 2024, through ongoing discussions with its key economic stakeholders, including a group of certain of the beneficial holders of the Company’s Variable Rate Convertible Senior Secured Notes due 2025 (the “2025 Notes”) and the Official Committee of Unsecured Creditors in the Bankruptcy Case (collectively, the “Consultation Parties”), UpHealth Holdings has determined that the sale of UpHealth Holdings’ equity interest in its wholly-owned non-debtor subsidiary TTC Healthcare, Inc. (“TTC”) may be appropriate to maximize value to the UpHealth Holdings’ estate because a sale of the equity interests in TTC may provide funding necessary for UpHealth Holdings to consummate a Chapter 11 plan and successfully exit its Chapter 11 case. In furtherance of the anticipated sales process, UpHealth Holdings selected, after consulting with the Consultation Parties, an investment banker, Stout Capital, LLC (“Stout”), to assist in a marketing and sale process to identify a party ready, willing and able to consummate a transaction, with the engagement of Stout approved by the Bankruptcy Court. In addition, as previously disclosed by the Company, UpHealth Holdings anticipates that it will pursue confirmation of a liquidating plan (including seeking approval of a related disclosure statement) alongside of the sale process.
On June 26, 2024, the Bankruptcy Court approved UpHealth Holdings’ employment of Stout to provide financial and investment banking services in connection with a sale of UpHealth Holdings’ equity interests in TTC. Furthermore, on July 17, 2024, UpHealth Holdings filed a motion before the Bankruptcy Court (the “Initial Bid Procedures Motion”) to approve procedures applicable to the sale of its equity interests in TTC and authorize the sale to the successful bidder of such equity interests free and clear of all liens, claims, encumbrances and other interests. On August 6, 2024, the Bankruptcy Court entered an order (the “Bidding Procedures Order”) granting the Initial Bid Procedures Motion and approving the proposed bidding procedures, pursuant to which UpHealth Holdings was authorized to designate a stalking horse bidder by September 10, 2024 (including by offering bid protections), by filing a supplement to the Initial Bid Procedures Motion. Furthermore, under the Bidding Procedures Order, the deadline for interested parties to submit a bid was September 12, 2024. Consistent with the Bidding Procedures Order, notice of the sale of TTC and auction process was provided to all creditors, including the Consultation Parties, and other required notice parties.
Since filing the Initial Bid Procedures Motion, UpHealth Holdings, with the assistance of Stout, has solicited bids pursuant to the Bidding Procedures Order by engaging in a marketing and sale process to identify a party ready, willing and able to consummate a transaction for the sale of TTC. On September 20, 2024, as a result of this process and following extensive negotiations, and after conferring with Stout and its other professionals and the Consultation Parties, and in light of the status of the sale process, UpHealth Holdings entered into a non-binding letter of intent (the “Commitment Letter”) for the sale by UpHealth Holdings of its 100% equity interest in TTC, free and clear of all liens, claims and encumbrances, to an entity newly formed by Martin Beck, who previously served as the Chief Executive Officer of the Company until his resignation on July 10, 2024, and Freedom 3 Capital (such entity, the “Purchaser”), based on the belief of UpHealth Holdings that the Commitment Letter represents the best method currently available of maximizing the value for the TTC Interests. Furthermore, in accordance with the terms of the Commitment Letter, on September 22, 2024, UpHealth Holdings filed with the Bankruptcy Court pursuant to the Bidding Procedures Order a supplement to the Initial Bid Procedures Motion (the “Supplement”, and together with the Initial Bid Procedures Motion, the “Bid Procedures Motion”), to request the entry of an order authorizing UpHealth Holdings to enter into and perform under the Commitment Letter, including all of the binding provisions thereof, and requesting related relief. A hearing to decide this matter has been scheduled by the Bankruptcy Court for October 9, 2024, and the entry into, and performance of, the Commitment Letter by UpHealth Holdings remain subject to approval by the Bankruptcy Court.
The Commitment Letter provides a purchase price for TTC of $11.0 million (assuming that TTC is debt-free, cash-free and has working capital consistent with the business having been operating in the ordinary course since the last audit, and that no material undisclosed liabilities are uncovered in diligence), with such amount to be payable in cash at closing of the sale. The transaction contemplated by the Commitment Letter is subject to the completion of confirmatory legal diligence and the negotiation by the parties of the definitive stock purchase agreement for the transaction (the “SPA”), which are expected to be completed within three and four weeks, respectively, from the date of execution of the Commitment Letter. The parties have agreed, subject to approval by the Bankruptcy Court, to a four-week exclusivity period commencing on the date of execution of the Commitment Letter and ending on and including October 18, 2024 (the “Exclusivity Period”), during which time UpHealth Holdings and TTC have agreed that they will not, and UpHealth Holdings will cause their affiliates and representatives not to: (i) discuss, negotiate, participate in, propose, authorize, enter into or consummate any agreement for, or (ii) solicit, continue or conduct any discussions, inquiries or negotiations or otherwise knowingly facilitate any submission of proposals or offers in respect of, a similar alternative transaction involving equity interests in, or material assets of, TTC.